# XELJANZ
> **NDA203214** · New Drug Application · Sponsor: PF PRISM CV · Approved 2012-11-06
## Drug
- **FDA Application Number:** NDA203214
- **Application type:** New Drug Application
- **Brand name:** XELJANZ
- **Generic name:** TOFACITINIB
- **Active ingredients:** TOFACITINIB CITRATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PF PRISM CV
- **Manufacturer:** Pfizer Laboratories Div Pfizer Inc
- **First approval:** 2012-11-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203214)
---
*AI Analytics · CC0 1.0*